Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Debt to Total Equity | 0.1x | 0.1x | 0.1x | 0.0x | 0.1x | 0.0x | 0.1x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.1x | 0.2x | 0.4x | 0.3x | 0.3x |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Total Debt to Total Equity is 0.5x, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Total Debt to Total Equity for Novo Nordisk A/S have been 0.3x over the past three years, and 0.3x over the past five years.
As of today, Novo Nordisk A/S's Total Debt to Total Equity is 0.5x, which is higher than industry median of 0.0x. It indicates that Novo Nordisk A/S's Total Debt to Total Equity is Bad.